Autofuser
510(k) K060258
Active
510(k)
Valid until
No expiry
FDA recalls
None ongoingDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK060258 | Date30 May 2006 | StatusActive |
Recalls
-
- Terminated Z-1859-2009
- Terminated Z-1857-2009
- Terminated Z-1836-2009
- Terminated Z-1825-2009
- Terminated Z-1864-2009
- Terminated Z-1837-2009
- Terminated Z-1854-2009
- Terminated Z-1855-2009
- Terminated Z-1862-2009
- Terminated Z-1841-2009
- Terminated Z-1867-2009
- Terminated Z-1829-2009
- Terminated Z-1847-2009
- Terminated Z-1839-2009
- Terminated Z-1824-2009
- Terminated Z-1830-2009
- Terminated Z-1835-2009
- Terminated Z-1851-2009
- Terminated Z-1863-2009
- Terminated Z-1842-2009
- Terminated Z-1850-2009
- Terminated Z-1844-2009
- Terminated Z-1852-2009
- Terminated Z-1831-2009
- Terminated Z-1845-2009
- Terminated Z-1832-2009
- Terminated Z-1849-2009
- Terminated Z-1861-2009
- Terminated Z-1838-2009
- Terminated Z-1866-2009
- Terminated Z-1846-2009
- Terminated Z-1840-2009
- Terminated Z-1827-2009
- Terminated Z-1826-2009
- Terminated Z-1853-2009
- Terminated Z-1856-2009
- Terminated Z-1823-2009
- Terminated Z-1828-2009
- Terminated Z-1868-2009
- Terminated Z-1843-2009
- Terminated Z-1858-2009
- Terminated Z-1833-2009
- Terminated Z-1865-2009
- Terminated Z-1860-2009
- Terminated Z-1834-2009
Failure to infuse and potential compromised sterility: The seal on the tyvek tray cover may fail, compromising sterility, and the device may fail to infuse the drug, resulting in a loss of pain mitigation.
-
- Terminated Z-1848-2009
TFailure to infuse and potential compromised sterility: he seal on the tyvek tray cover may fail, compromising sterility, and the device may fail to infuse the drug, resulting in a loss of pain mitigation.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- MEB
- Device Class
- Class II
- Regulation
- 21 CFR Part 880.5725
- Advisory Committee
- General Hospital
- FDA Decision
- SESE Substantially Equivalent